Skip to main content
Top
Published in: BMC Oral Health 1/2014

Open Access 01-12-2014 | Research article

Two-year randomized clinical trial of enamel matrix derivative treated infrabony defects: radiographic analysis

Authors: Mariana Schutzer Ragghianti Zangrando, Daniela Chambrone, Ivan Munhoz Pasin, Marina Clemente Conde, Cláudio Mendes Pannuti, Luiz Antônio Pugliesi Alves de Lima

Published in: BMC Oral Health | Issue 1/2014

Login to get access

Abstract

Background

This split-mouth, double-blind randomized controlled trial evaluated radiographic changes in infrabony defects treated with open flap debridement (OFD) or OFD associated with enamel matrix derivative (EMD) after a 24–month follow-up. The radiographic distance from the CEJ to the bottom of the defect (BD) was considered the primary outcome. CEJ-BC and defect angle were secondary outcomes.

Methods

Ten patients presenting 2 or more defects were selected. An individualized film holder was used to take standardized radiographs of the 43 defects, at baseline and after 24 months. Images were digitized and used to measure the distances from the cemento-enamel junction (CEJ) to the alveolar crest (AC), CEJ to the bottom of the defect (BD) and infrabony defect angle. Statistical analysis was performed in SPSS for Windows (version 5.2). Paired samples t test was used to compare test and control groups and to evaluate changes within each group. The level of significance was set at α = 0.05%.

Results

After 24 months, a significant crestal bone loss was observed for EMD (1.01 mm; p = 0.049) but not for OFD (0.14 mm; p = 0.622). However, no differences were detected between groups (p = 0.37). Reduction of the bone defect depth was significant for OFD (0.70 mm; p = 0.005) but not for EMD (0.04 mm; p = 0.86), while no differences were detected between them (p = 0.87). Both EMD (0.69°; p = 0.82) and OFD (5.71°; p = 0.24) showed an improvement in defect angle measurements but no significant differences were observed after 24 months or between the groups (p = 0.35).

Conclusion

Linear radiographic analysis was not able to demonstrate superiority of EMD treated infrabony defects when compared to ODF after 24 months.

Trial registration

ClinicalTrials.gov: NCT02195765. Registered 17 July 2014.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Academy of Periodontology: Glossary of Periodontal Terms. 2001, Chicago: American Academy of Periodontology, 44-4 American Academy of Periodontology: Glossary of Periodontal Terms. 2001, Chicago: American Academy of Periodontology, 44-4
2.
go back to reference Hoang AM, Oates TW, Cochran DL: In vitro wound healing responses to enamel matrix derivative. J Periodontol. 2000, 71: 1270-1277. 10.1902/jop.2000.71.8.1270.CrossRefPubMed Hoang AM, Oates TW, Cochran DL: In vitro wound healing responses to enamel matrix derivative. J Periodontol. 2000, 71: 1270-1277. 10.1902/jop.2000.71.8.1270.CrossRefPubMed
3.
go back to reference Hammarström L: Enamel matrix, cementum development and regeneration. J Clin Periodontol. 1997, 24: 658-668. 10.1111/j.1600-051X.1997.tb00247.x.CrossRefPubMed Hammarström L: Enamel matrix, cementum development and regeneration. J Clin Periodontol. 1997, 24: 658-668. 10.1111/j.1600-051X.1997.tb00247.x.CrossRefPubMed
4.
go back to reference Kalpidis CDR, Ruben MP: Treatment of infrabony periodontal defects with enamel matrix derivative: a literature review. J Periodontol. 2002, 73: 1360-1376. 10.1902/jop.2002.73.11.1360.CrossRefPubMed Kalpidis CDR, Ruben MP: Treatment of infrabony periodontal defects with enamel matrix derivative: a literature review. J Periodontol. 2002, 73: 1360-1376. 10.1902/jop.2002.73.11.1360.CrossRefPubMed
5.
go back to reference Heijl L, Heden G, Svärdström G, Ostgren A: Enamel matrix derivative (EMDOGAIN®) in the treatment of infrabony periodontal defects. J Clin Periodontol. 1997, 24: 705-714. 10.1111/j.1600-051X.1997.tb00253.x.CrossRefPubMed Heijl L, Heden G, Svärdström G, Ostgren A: Enamel matrix derivative (EMDOGAIN®) in the treatment of infrabony periodontal defects. J Clin Periodontol. 1997, 24: 705-714. 10.1111/j.1600-051X.1997.tb00253.x.CrossRefPubMed
6.
go back to reference Zetterström O, Andersson C, Eriksson L, Fredriksson A, Friskopp J, Heden G, Jansson B, Lundgren T, Nilveus R, Olsson A, Renvert S, Salonen L, Sjöström L, Winell A, Ostgren A, Gestrelius S: Clinical safety of enamel matrix derivative (Emdogain®) in the treatment of periodontal defects. J Clin Periodontol. 1997, 24: 697-704. 10.1111/j.1600-051X.1997.tb00252.x.CrossRefPubMed Zetterström O, Andersson C, Eriksson L, Fredriksson A, Friskopp J, Heden G, Jansson B, Lundgren T, Nilveus R, Olsson A, Renvert S, Salonen L, Sjöström L, Winell A, Ostgren A, Gestrelius S: Clinical safety of enamel matrix derivative (Emdogain®) in the treatment of periodontal defects. J Clin Periodontol. 1997, 24: 697-704. 10.1111/j.1600-051X.1997.tb00252.x.CrossRefPubMed
7.
go back to reference Okuda K, Momose M, Miyazaki A, Murata M, Yokoyama S, Yonezawa Y, Wolff LF, Yoshie H: Enamel matrix derivative in the treatment of human infrabony osseous defects. J Periodontol. 2000, 71: 1821-1828. 10.1902/jop.2000.71.12.1821.CrossRefPubMed Okuda K, Momose M, Miyazaki A, Murata M, Yokoyama S, Yonezawa Y, Wolff LF, Yoshie H: Enamel matrix derivative in the treatment of human infrabony osseous defects. J Periodontol. 2000, 71: 1821-1828. 10.1902/jop.2000.71.12.1821.CrossRefPubMed
8.
go back to reference Francetti L, Del Fabbro M, Basso M, Testori T, Weinstein R: Enamel matrix proteins in the treatment of infrabony defects. A prospective 24-month clinical trial. J Clin Periodontol. 2004, 31: 52-59. 10.1111/j.0303-6979.2004.00437.x.CrossRefPubMed Francetti L, Del Fabbro M, Basso M, Testori T, Weinstein R: Enamel matrix proteins in the treatment of infrabony defects. A prospective 24-month clinical trial. J Clin Periodontol. 2004, 31: 52-59. 10.1111/j.0303-6979.2004.00437.x.CrossRefPubMed
9.
go back to reference Rösing CK, Aass AM, Mavropoulos A, Gjermo P: Clinical and radiographic effects of enamel matrix derivative in the treatment of infrabony periodontal defects: a 12-month longitudinal placebo-controlled clinical trial in adult periodontitis patients. J Periodontol. 2005, 76: 129-133. 10.1902/jop.2005.76.1.129.CrossRefPubMed Rösing CK, Aass AM, Mavropoulos A, Gjermo P: Clinical and radiographic effects of enamel matrix derivative in the treatment of infrabony periodontal defects: a 12-month longitudinal placebo-controlled clinical trial in adult periodontitis patients. J Periodontol. 2005, 76: 129-133. 10.1902/jop.2005.76.1.129.CrossRefPubMed
10.
go back to reference Chambrone D, Pasin IM, Conde MC, Panutti C, Carneiro S, Lima LA: Effect of enamel matrix proteins on the treatment of infrabony defects: a split-mouth randomized controlled trial study. Braz Oral Res. 2007, 21: 241-246.CrossRefPubMed Chambrone D, Pasin IM, Conde MC, Panutti C, Carneiro S, Lima LA: Effect of enamel matrix proteins on the treatment of infrabony defects: a split-mouth randomized controlled trial study. Braz Oral Res. 2007, 21: 241-246.CrossRefPubMed
11.
go back to reference Grusovin MG, Esposito M: The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: a placebo-controlled randomized clinical trial. Eur J Oral Implantol. 2009, 2: 43-54.PubMed Grusovin MG, Esposito M: The efficacy of enamel matrix derivative (Emdogain) for the treatment of deep infrabony periodontal defects: a placebo-controlled randomized clinical trial. Eur J Oral Implantol. 2009, 2: 43-54.PubMed
12.
go back to reference Chambrone D, Pasin I, Chambrone L, Pannuti CM, Conde MC, Lima LA: Treatment of infrabony defects with and without enamel matrix proteins: 24-month follow-up randomized pilot study. Quintessence Int. 2010, 41: 125-134.PubMed Chambrone D, Pasin I, Chambrone L, Pannuti CM, Conde MC, Lima LA: Treatment of infrabony defects with and without enamel matrix proteins: 24-month follow-up randomized pilot study. Quintessence Int. 2010, 41: 125-134.PubMed
13.
go back to reference Ribeiro FV, Casarin RC, Júnior FH, Sallum EA, Casati MZ: The role of enamel matrix derivative protein in minimally invasive surgery in treating intrabony defects in single-rooted teeth: a randomized clinical trial. J Periodontol. 2011, 82: 522-532. 10.1902/jop.2010.100454.CrossRefPubMed Ribeiro FV, Casarin RC, Júnior FH, Sallum EA, Casati MZ: The role of enamel matrix derivative protein in minimally invasive surgery in treating intrabony defects in single-rooted teeth: a randomized clinical trial. J Periodontol. 2011, 82: 522-532. 10.1902/jop.2010.100454.CrossRefPubMed
14.
go back to reference Bhutda G, Deo V: Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controlled trial. Acta Odontol Scand. 2013, 71: 764-770. 10.3109/00016357.2012.728245.CrossRefPubMed Bhutda G, Deo V: Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: a randomized controlled trial. Acta Odontol Scand. 2013, 71: 764-770. 10.3109/00016357.2012.728245.CrossRefPubMed
15.
go back to reference Reddy MS, Jeffcoat MK: Methods of assessing periodontal regeneration. Periodontology 2000. 1999, 19: 87-103. 10.1111/j.1600-0757.1999.tb00149.x.CrossRefPubMed Reddy MS, Jeffcoat MK: Methods of assessing periodontal regeneration. Periodontology 2000. 1999, 19: 87-103. 10.1111/j.1600-0757.1999.tb00149.x.CrossRefPubMed
16.
go back to reference Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV: Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in infrabony defects. Cochrane Database Syst Rev. The Cochrane Library (Issue 6):Art. No. CD003875. doi:10.1002/14651858.CD003875.pub2 Esposito M, Grusovin MG, Papanikolaou N, Coulthard P, Worthington HV: Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in infrabony defects. Cochrane Database Syst Rev. The Cochrane Library (Issue 6):Art. No. CD003875. doi:10.1002/14651858.CD003875.pub2
17.
go back to reference Armitage GC: International workshop for a classification of periodontal diseases and conditions. Ann Periodontol. 1999, 4: 1-6. 10.1902/annals.1999.4.1.1.CrossRefPubMed Armitage GC: International workshop for a classification of periodontal diseases and conditions. Ann Periodontol. 1999, 4: 1-6. 10.1902/annals.1999.4.1.1.CrossRefPubMed
18.
go back to reference O’Leary TJ, Rudd KD: An instrument for measuring horizontal mobility. Periodontics. 1963, 1: 249- O’Leary TJ, Rudd KD: An instrument for measuring horizontal mobility. Periodontics. 1963, 1: 249-
19.
go back to reference O’Leary TJ, Drake RB, Naylor JE: The plaque control record. J Periodontol. 1972, 43: 38-10.1902/jop.1972.43.1.38.CrossRefPubMed O’Leary TJ, Drake RB, Naylor JE: The plaque control record. J Periodontol. 1972, 43: 38-10.1902/jop.1972.43.1.38.CrossRefPubMed
20.
go back to reference Björn H, Halling A, Thyberg H: Radiographic assessment of marginal bone loss. Odontol Revy. 1969, 20: 165-179.PubMed Björn H, Halling A, Thyberg H: Radiographic assessment of marginal bone loss. Odontol Revy. 1969, 20: 165-179.PubMed
21.
go back to reference Steffensen B, Weber HP: Relationship between radiographic periodontal defect angle and healing after treatment. J Periodontol. 1989, 60: 248-253. 10.1902/jop.1989.60.5.248.CrossRefPubMed Steffensen B, Weber HP: Relationship between radiographic periodontal defect angle and healing after treatment. J Periodontol. 1989, 60: 248-253. 10.1902/jop.1989.60.5.248.CrossRefPubMed
22.
go back to reference Tonetti MS, Pini-Prato G, Cortellini P: Effect of cigarette smoking on long -term clinical results of infrabony defects treated with regenerative therapy: a preliminary retrospective study. J Clin Periodontol. 1995, 22: 229-234.CrossRefPubMed Tonetti MS, Pini-Prato G, Cortellini P: Effect of cigarette smoking on long -term clinical results of infrabony defects treated with regenerative therapy: a preliminary retrospective study. J Clin Periodontol. 1995, 22: 229-234.CrossRefPubMed
23.
go back to reference Christgau M, Wenzel A, Hiller KA, Schmalz G: Quantitative digital subtraction radiography for assessment of bone density changes following periodontal guided tissue regeneration. Dentomaxillofac Radiol. 1996, 25: 25-33. 10.1259/dmfr.25.1.9084282.CrossRefPubMed Christgau M, Wenzel A, Hiller KA, Schmalz G: Quantitative digital subtraction radiography for assessment of bone density changes following periodontal guided tissue regeneration. Dentomaxillofac Radiol. 1996, 25: 25-33. 10.1259/dmfr.25.1.9084282.CrossRefPubMed
24.
go back to reference Eickholz P, Hausmann E: Evidence for healing of interproximal infrabony defects after conventional and regenerative therapy: digital radiography and clinical measurements. J Periodontol Res. 1998, 33: 156-165.CrossRef Eickholz P, Hausmann E: Evidence for healing of interproximal infrabony defects after conventional and regenerative therapy: digital radiography and clinical measurements. J Periodontol Res. 1998, 33: 156-165.CrossRef
25.
go back to reference Zanatta FB, Souza FG, Pinto TMP, Antoniazzi RP, Rösing CK: Do the clinical effects of enamel matrix derivatives in infrabony defects decrease overtime? A systematic review and meta-analysis. Braz Dent J. 2013, 24: 446-455. 10.1590/0103-6440201302192.CrossRefPubMed Zanatta FB, Souza FG, Pinto TMP, Antoniazzi RP, Rösing CK: Do the clinical effects of enamel matrix derivatives in infrabony defects decrease overtime? A systematic review and meta-analysis. Braz Dent J. 2013, 24: 446-455. 10.1590/0103-6440201302192.CrossRefPubMed
26.
go back to reference Gestrelius S, Andersson C, Johansson AC, Persson E, Brodin A, Rydhag L, Hammarström L: Formulation of enamel matrix derivative for surface coating: kinectics and cell colonization. J Clin Periodontol. 1997, 24: 678-684. 10.1111/j.1600-051X.1997.tb00249.x.CrossRefPubMed Gestrelius S, Andersson C, Johansson AC, Persson E, Brodin A, Rydhag L, Hammarström L: Formulation of enamel matrix derivative for surface coating: kinectics and cell colonization. J Clin Periodontol. 1997, 24: 678-684. 10.1111/j.1600-051X.1997.tb00249.x.CrossRefPubMed
27.
go back to reference Hama H, Azuma H, Seto H, Kido J, Nagata T: Inhibitory effect of enamel matrix derivative on osteoblastic differentiation of rat calvaria cells in culture. J Periodontol Res. 2008, 43: 179-185. 10.1111/j.1600-0765.2007.01010.x.CrossRef Hama H, Azuma H, Seto H, Kido J, Nagata T: Inhibitory effect of enamel matrix derivative on osteoblastic differentiation of rat calvaria cells in culture. J Periodontol Res. 2008, 43: 179-185. 10.1111/j.1600-0765.2007.01010.x.CrossRef
28.
go back to reference Plachokova AS, Dolder J, Jansen JA: The bone-regenerative properties of Emdogain adsorbed onto poly (D, L-lactic-coglycolic acid)/calcium phosphate composites in an ectopic and an orthotopic rat model. J Periodontol Res. 2008, 43: 55-63. Plachokova AS, Dolder J, Jansen JA: The bone-regenerative properties of Emdogain adsorbed onto poly (D, L-lactic-coglycolic acid)/calcium phosphate composites in an ectopic and an orthotopic rat model. J Periodontol Res. 2008, 43: 55-63.
29.
go back to reference Windisch P, Sculean A, Klein F, Tóth V, Gera I, Reich E, Eickholz P: Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects. J Periodontol. 2002, 73: 409-417. 10.1902/jop.2002.73.4.409.CrossRefPubMed Windisch P, Sculean A, Klein F, Tóth V, Gera I, Reich E, Eickholz P: Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects. J Periodontol. 2002, 73: 409-417. 10.1902/jop.2002.73.4.409.CrossRefPubMed
30.
go back to reference Lindhe J, Nyman S, Karring T: Connective tissue reattachment as related to presence or absence of alveolar bone. J Clin Periodontol. 1984, 11: 33-40. 10.1111/j.1600-051X.1984.tb01306.x.CrossRefPubMed Lindhe J, Nyman S, Karring T: Connective tissue reattachment as related to presence or absence of alveolar bone. J Clin Periodontol. 1984, 11: 33-40. 10.1111/j.1600-051X.1984.tb01306.x.CrossRefPubMed
31.
go back to reference Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B: Enamel matrix proteins in the regenerative therapy of deep infrabony defects. J Clin Periodontol. 2002, 29: 317-325. 10.1034/j.1600-051X.2002.290407.x.CrossRefPubMed Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B: Enamel matrix proteins in the regenerative therapy of deep infrabony defects. J Clin Periodontol. 2002, 29: 317-325. 10.1034/j.1600-051X.2002.290407.x.CrossRefPubMed
32.
go back to reference Cortellini P, PiniPrato GP, Tonetti MS: Long-term stability of clinical attachment following guided tissue regeneration and conventional therapy. J Clin Periodontol. 1996, 23: 106-111. 10.1111/j.1600-051X.1996.tb00542.x.CrossRefPubMed Cortellini P, PiniPrato GP, Tonetti MS: Long-term stability of clinical attachment following guided tissue regeneration and conventional therapy. J Clin Periodontol. 1996, 23: 106-111. 10.1111/j.1600-051X.1996.tb00542.x.CrossRefPubMed
33.
go back to reference Trombelli L, Kim CK, Zimmerman GJ, Wikesjö UM: Retrospective analysis of factors related to clinical outcome of guided tissue regeneration procedures in intra- bony defects. J Clin Periodontol. 1997, 24: 366-371. 10.1111/j.1600-051X.1997.tb00199.x.CrossRefPubMed Trombelli L, Kim CK, Zimmerman GJ, Wikesjö UM: Retrospective analysis of factors related to clinical outcome of guided tissue regeneration procedures in intra- bony defects. J Clin Periodontol. 1997, 24: 366-371. 10.1111/j.1600-051X.1997.tb00199.x.CrossRefPubMed
Metadata
Title
Two-year randomized clinical trial of enamel matrix derivative treated infrabony defects: radiographic analysis
Authors
Mariana Schutzer Ragghianti Zangrando
Daniela Chambrone
Ivan Munhoz Pasin
Marina Clemente Conde
Cláudio Mendes Pannuti
Luiz Antônio Pugliesi Alves de Lima
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2014
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/1472-6831-14-149

Other articles of this Issue 1/2014

BMC Oral Health 1/2014 Go to the issue